|
|
-
St. Jude Medical Announces CE Mark Approval Of ILUMIEN OPTIS PCI Optimization System
5/16/2013
|
|
|
-
St. Jude Medical Announces 1st Patient Enrollment In EnligHTN III Renal Denervation Study Of Next-Gen EnligHTN System
5/14/2013
|
-
St. Jude Medical Announces Results From Independent Analysis Of Optim-Insulated Defibrillation Leads
5/9/2013
|
-
Barclays Capital Reiterates St. Jude Medical Inc. (STJ) At Overweight With $48 Price Target
5/9/2013
|
|
|
-
St. Jude Medical Announces CE Mark Approval Of Next-Generation Ellipse And SJM Assura High Voltage Devices
5/8/2013
|
-
St. Jude Medical Declares Quarterly Dividend Of $0.25, Payable July 31/ Record June 28
5/1/2013
|
-
St. Jude Medical Inc. (STJ) Declares $ 0.25 Dividend for Q2 13, Record Date 6/28/2013
5/1/2013
|